Page 14 - Analytical Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation. Charles River Partners with JADE Biomedical to Expand Biologics Capabilities January 14, 2021 GMT WILMINGTON, Mass. & SHANGHAI--(BUSINESS WIRE)--Jan 14, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with JADE Biomedical (JADE), a provider of end-to-end quality management services for the biopharmaceutical industry. The partnership will expand Charles River’s biologics testing capabilities geographically and help to...

Share this article Share this article SEOUL, South Korea, Jan. 12, 2021 /PRNewswire/ -- Hanmi Pharmaceutical Co., Ltd., announced "endless challenges and new commitments for the pharmaceutical industry" as their management slogan for the new year, presenting the business direction for the year 2021 at the 39th JP Morgan Healthcare Conference, which was held online. Hanmi Pharmaceutical Co., Ltd Bio Plant manufacturing and Development facilities. A view of the Pyeongtaek Bio Plant of Hanmi Pharmaceutical Co., Ltd. During the day's presentation, Hanmi Pharmaceutical Co., Ltd. drew attention by...

DiNAQOR Establishes New GMP Manufacturing Facility in Zurich News provided by Share this article Share this article PFÄFFIKON, Switzerland, Jan. 11, 2021 /PRNewswire/ -- DiNAQOR, a gene therapy platform company, today announced that it will establish its own GMP manufacturing capabilities with a new facility in the Bio-Technopark Schlieren-Zürich. This state-of-the-art 1200 sqm (13,000 sq. ft) GMP facility will produce adeno-associated virus (AAV)-based gene therapies and is co-located with DiNAQOR's Research & Development (R&D) facility. "Establishing DiNAQOR's own gene therapy manufa...